696 related articles for article (PubMed ID: 26652799)
1. Allergen extracts for immunotherapy: to mix or not to mix?
Nony E; Martelet A; Jain K; Moingeon P
Expert Rev Clin Pharmacol; 2016; 9(3):401-8. PubMed ID: 26652799
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
3. Treatment of respiratory allergy with allergy immunotherapy tablets.
Bachert C
Allergy; 2011 Jul; 66 Suppl 95():57-9. PubMed ID: 21668858
[TBL] [Abstract][Full Text] [Related]
4. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
5. Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient.
Nelson HS
Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1443-1451. PubMed ID: 27687128
[TBL] [Abstract][Full Text] [Related]
6. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
[TBL] [Abstract][Full Text] [Related]
7. Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.
Batard T; Baron-Bodo V; Martelet A; Le Mignon M; Lemoine P; Jain K; Mariano S; Horiot S; Chabre H; Harwanegg C; Marquette CA; Corgier BP; Soh WT; Satitsuksanoa P; Jacquet A; Chew FT; Nony E; Moingeon P
Allergy; 2016 Feb; 71(2):220-9. PubMed ID: 26485347
[TBL] [Abstract][Full Text] [Related]
8. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis.
Gangl K; Niederberger V; Valenta R
Clin Exp Allergy; 2013 Nov; 43(11):1202-16. PubMed ID: 24152153
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of house dust mite allergy.
Yang L; Zhu R
Hum Vaccin Immunother; 2017 Oct; 13(10):2390-2396. PubMed ID: 28853977
[TBL] [Abstract][Full Text] [Related]
10. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
11. House dust mite-specific immunotherapy alters the natural course of atopic march.
Tang RB
J Chin Med Assoc; 2020 Feb; 83(2):109-112. PubMed ID: 32015265
[TBL] [Abstract][Full Text] [Related]
12. Progress in the development of specific immunotherapies for house dust mite allergies.
Moingeon P
Expert Rev Vaccines; 2014 Dec; 13(12):1463-73. PubMed ID: 25187166
[TBL] [Abstract][Full Text] [Related]
13. A milestone in house dust-mite-allergen immunotherapy: the new sublingual tablet S-524101 (actair).
Bahceciler NN; Babayigit Hocaoglu A; Galip N
Expert Rev Vaccines; 2014 Dec; 13(12):1427-38. PubMed ID: 25345538
[TBL] [Abstract][Full Text] [Related]
14. Specific immunotherapy with allergen mixes: what is the evidence?
Nelson HS
Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):549-53. PubMed ID: 19745727
[TBL] [Abstract][Full Text] [Related]
15. Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA.
Guan K; Liu B; Wang M; Li Z; Chang C; Cui L; Wang RQ; Wen LP; Leung PSC; Wei JF; Sun JL
Clin Rev Allergy Immunol; 2019 Aug; 57(1):128-143. PubMed ID: 31243705
[TBL] [Abstract][Full Text] [Related]
16. Next generation immunotherapy for tree pollen allergies.
Su Y; Romeu-Bonilla E; Heiland T
Hum Vaccin Immunother; 2017 Oct; 13(10):2402-2415. PubMed ID: 28853984
[TBL] [Abstract][Full Text] [Related]
17. Induction of allergen-specific tolerance via mucosal routes.
Mascarell L; Zimmer A; Van Overtvelt L; Tourdot S; Moingeon P
Curr Top Microbiol Immunol; 2011; 352():85-105. PubMed ID: 21562971
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
19. Distinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen-specific immunotherapy.
Schulten V; Tripple V; Aasbjerg K; Backer V; Lund G; Würtzen PA; Sette A; Peters B
Clin Exp Allergy; 2016 Mar; 46(3):439-48. PubMed ID: 26436865
[TBL] [Abstract][Full Text] [Related]
20. Scientific foundations of allergen-specific immunotherapy for allergic disease.
Soyka MB; van de Veen W; Holzmann D; Akdis M; Akdis CA
Chest; 2014 Nov; 146(5):1347-1357. PubMed ID: 25367471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
